Seeking Alpha

RJCogburn's  Instablog

Send Message
I imagine myself as having the courage, determination, and loyalty as my screen name icon but will settle for two out of three. Retired, investing has become a wonderful avocation.
View RJCogburn's Instablogs on:
  • OPTR...Receives Milestone Payment From Cempra for Next-Generation Macrolide Antibiotic
    OPTR's drug nearest to approval is fidaxomicin, a promising treatment for C. diff infection which is a growing problem with only a couple of current drug treatments.  Next in line is Purvel for infectious dirrahea.  Both these have completed two phase 3 trials.

    The news regarding a next generation macrolide was a bit of a surprise.  A successful phase one study resulted in a $500,000 payment to OPTR from Cempra Pharmaceuticals per a licensing agreement. 

    The company has promising drugs, but still a ways to go.  How to value the company is problematic and the stock price has been steadily dropping since mid March and trades near its one year low.
    Tags: OPTR
    Jul 10 7:27 AM | Link | 1 Comment
Full index of posts »
Latest Followers

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.